Wilson and Jungner would not approve of screening for atrial fibrillation
- PMID: 31018937
- DOI: 10.1136/bmj.l1416
Wilson and Jungner would not approve of screening for atrial fibrillation
Conflict of interest statement
Competing interests: The author has received honorariums/speaking fees from Boehringer-Ingelheim, Bayer, and Pfizer/Bristol-Myers Squibb.
Comment in
-
Screening for atrial fibrillation: waiting for randomised trial data.BMJ. 2019 Jun 4;365:l2383. doi: 10.1136/bmj.l2383. BMJ. 2019. PMID: 31164337 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical